Fingerprint
Dive into the research topics of 'Eganelisib: Phosphatidylinositol 3-kinase γ (PI3Kγ) inhibitor Treatment of triple-negative breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Eganelisib: Phosphatidylinositol 3-kinase γ (PI3Kγ) inhibitor Treatment of triple-negative breast cancer
L. Bo, Y. K. Zhang, S. E. Reznik, Z. S. Chen
Research output: Contribution to journal › Article › peer-review